CAI
Caris Life SciencesBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Composite grade B from latest DB weights. Momentum 96.1 / Value 58.3
Posture
Constructive
Lead driver
Value
What changed
6 setup hits (3d) with net bullish as of 2026-09-09.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
96
Value
58
Sentiment
N/A
Setup hits (3d)
6 · Net Bullish
AI TargetsBase - · Bull - · Bear -Analysis date unavailable; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-08 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-09-08
Investment thesis
As of 2026-09-08
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-08. Definitions
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Bullish
Target $27.33
Why
Momentum96 · Δ7d +1.9
Value58 · Δ7d -0.0
SentimentN/A · Δ7d -
So what
Strength-led posture (Net Bullish). Favor watchlist adds and disciplined entries.
Confirming evidence
- • 6 setup hits (3d) with net bullish as of 2026-09-09.
- • Value remains the lead driver in the composite, 7D delta -0.0.
Contradictions & invalidation
- • Mixed signals. Wait for cleaner trend confirmation.
Catalyst clock
No dated catalyst is available.
Lead driver: Value · See fundamentals
Momentum
96
25% active weight
Current posture
7d trendImproving
Δ7d
+1.9
Δ21d
+12.4
Value
58
75% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+3.4
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade B. Momentum 96.1 / Value 58.3
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$6.11B
Beta
-
Shares Out
282.6M
P/E (TTM) · Derived
-11.4
P/S (TTM)
-
P/FCF (TTM) · Derived
52.54
Rev YoY
+45.4%
EPS YoY
-99.9%
Gross Margin
+69.7%
Op Margin
+15.5%
Net Debt
-$372.41M
Current Ratio
5.53
As of 2026-09-08 • Updated nightlySource: Internal modelMethods & Data